Cargando…

Management challenges with brown tumor of primary hyperparathyroidism masked by severe vitamin D deficiency: a case report

BACKGROUND: Hyperparathyroidism is a disease characterized by excessive secretion of parathyroid hormone, the hormone responsible for calcium and phosphate homeostasis in the body. It can be of three types: primary, secondary, or tertiary. It is essential to bear in mind that in any one patient more...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Marya, Hammam, Montasir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899912/
https://www.ncbi.nlm.nih.gov/pubmed/27277007
http://dx.doi.org/10.1186/s13256-016-0933-4
_version_ 1782436553135489024
author Hussain, Marya
Hammam, Montasir
author_facet Hussain, Marya
Hammam, Montasir
author_sort Hussain, Marya
collection PubMed
description BACKGROUND: Hyperparathyroidism is a disease characterized by excessive secretion of parathyroid hormone, the hormone responsible for calcium and phosphate homeostasis in the body. It can be of three types: primary, secondary, or tertiary. It is essential to bear in mind that in any one patient more than one type of hyperparathyroidism may be found, which may create perplexity regarding the etiology of the case. Hyperparathyroidism can become apparent early in its course when a patient presents with symptoms of abdominal pain, recurrent renal calculi, repeated fractures, or behavior changes. It is generally accepted that bone involvement is a late manifestation of primary hyperparathyroidism. It is imperative to consider that some patients, such as our patient described in this report, may be previously asymptomatic clinically and on the basis of laboratory findings and present with only late skeletal manifestations. Brown tumors are one of the mimickers of lytic lesions of the jaw and need to be ruled out early in the course of management. Researchers in several studies published in high-impact journals have recommended the use of high-dose vitamin D as safe in patients with primary hyperparathyroidism without the risk of raising calcium levels significantly. In our patient, we observed considerable hypercalcemia after high-dose vitamin D therapy, and we propose exercising discretion with the use of high-dose therapies. CASE PRESENTATION: We report a case of a 21-year-old Arab woman with a brown tumor who presented with hypocalcaemia. She presented with a mixed picture of primary hyperparathyroidism and severe vitamin D deficiency. CONCLUSIONS: Brown tumors, although thought to be a forgotten entity with the advent of early screening for hypercalcemia, is still prevalent, as a handful of patients may present late in the disease course with no early markers, such as in our patient. We emphasize using a holistic approach for early diagnosis and adopting a restricted attitude to treating these benign entities, especially in the context of cosmesis for sensitive locations such as the face. In addition, we express caution in using daily supplementation with a high vitamin D dose to improve vitamin D status and decrease parathyroid hormone.
format Online
Article
Text
id pubmed-4899912
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48999122016-06-10 Management challenges with brown tumor of primary hyperparathyroidism masked by severe vitamin D deficiency: a case report Hussain, Marya Hammam, Montasir J Med Case Rep Case Report BACKGROUND: Hyperparathyroidism is a disease characterized by excessive secretion of parathyroid hormone, the hormone responsible for calcium and phosphate homeostasis in the body. It can be of three types: primary, secondary, or tertiary. It is essential to bear in mind that in any one patient more than one type of hyperparathyroidism may be found, which may create perplexity regarding the etiology of the case. Hyperparathyroidism can become apparent early in its course when a patient presents with symptoms of abdominal pain, recurrent renal calculi, repeated fractures, or behavior changes. It is generally accepted that bone involvement is a late manifestation of primary hyperparathyroidism. It is imperative to consider that some patients, such as our patient described in this report, may be previously asymptomatic clinically and on the basis of laboratory findings and present with only late skeletal manifestations. Brown tumors are one of the mimickers of lytic lesions of the jaw and need to be ruled out early in the course of management. Researchers in several studies published in high-impact journals have recommended the use of high-dose vitamin D as safe in patients with primary hyperparathyroidism without the risk of raising calcium levels significantly. In our patient, we observed considerable hypercalcemia after high-dose vitamin D therapy, and we propose exercising discretion with the use of high-dose therapies. CASE PRESENTATION: We report a case of a 21-year-old Arab woman with a brown tumor who presented with hypocalcaemia. She presented with a mixed picture of primary hyperparathyroidism and severe vitamin D deficiency. CONCLUSIONS: Brown tumors, although thought to be a forgotten entity with the advent of early screening for hypercalcemia, is still prevalent, as a handful of patients may present late in the disease course with no early markers, such as in our patient. We emphasize using a holistic approach for early diagnosis and adopting a restricted attitude to treating these benign entities, especially in the context of cosmesis for sensitive locations such as the face. In addition, we express caution in using daily supplementation with a high vitamin D dose to improve vitamin D status and decrease parathyroid hormone. BioMed Central 2016-06-09 /pmc/articles/PMC4899912/ /pubmed/27277007 http://dx.doi.org/10.1186/s13256-016-0933-4 Text en © Hussain and Hammam. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Hussain, Marya
Hammam, Montasir
Management challenges with brown tumor of primary hyperparathyroidism masked by severe vitamin D deficiency: a case report
title Management challenges with brown tumor of primary hyperparathyroidism masked by severe vitamin D deficiency: a case report
title_full Management challenges with brown tumor of primary hyperparathyroidism masked by severe vitamin D deficiency: a case report
title_fullStr Management challenges with brown tumor of primary hyperparathyroidism masked by severe vitamin D deficiency: a case report
title_full_unstemmed Management challenges with brown tumor of primary hyperparathyroidism masked by severe vitamin D deficiency: a case report
title_short Management challenges with brown tumor of primary hyperparathyroidism masked by severe vitamin D deficiency: a case report
title_sort management challenges with brown tumor of primary hyperparathyroidism masked by severe vitamin d deficiency: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899912/
https://www.ncbi.nlm.nih.gov/pubmed/27277007
http://dx.doi.org/10.1186/s13256-016-0933-4
work_keys_str_mv AT hussainmarya managementchallengeswithbrowntumorofprimaryhyperparathyroidismmaskedbyseverevitaminddeficiencyacasereport
AT hammammontasir managementchallengeswithbrowntumorofprimaryhyperparathyroidismmaskedbyseverevitaminddeficiencyacasereport